| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |